Sphera Funds Management Ltd. Orchard Therapeutics PLC Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $3.06 Million - $5.86 Million	-1,366,564 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $6 Million - $12.4 Million	1,366,564 New	1,366,564 $9.92 Million
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $1.28 Million - $1.8 Million	-107,433 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.63 $1.19 Million - $1.86 Million	-90,353 Reduced 45.68%	107,433 $0
Q1 2019 May 15, 2019	SELL	$12.01 - $19.49 $2.07 Million - $3.36 Million	-172,214 Reduced 46.54%	197,786 $3.54 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $4.59 Million - $6.92 Million	370,000 New	370,000 $5.82 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.